Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2010
10/26/2010CA2457780C Topical compositions and methods for treating pain
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2412164C Amidine derivatives as selective antagonists of nmda receptors
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/26/2010CA2398707C C1 inhibitor produced in the milk of transgenic mammals
10/26/2010CA2396956C Polypharmacophoric agents
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/26/2010CA2304700C Lipophilic diesters of chelating agents
10/26/2010CA2163111C Process for the preparation of an oral solid dosage form containing diclofenac
10/21/2010WO2010121225A2 Method of treating disorders associated with protein kinase ck2 activity
10/21/2010WO2010121046A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010WO2010121036A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010WO2010121011A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010WO2010120935A1 Anti-viral compounds
10/21/2010WO2010120374A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010WO2010120237A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119864A1 Peptide derivative
10/21/2010WO2010119741A1 Preparation for external use
10/21/2010WO2010118968A1 No-donor aspirin derivatives
10/21/2010WO2010118921A1 Novel p2x7r antagonists and their use
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010091892A3 Alkylamido compounds and uses thereof
10/21/2010WO2010087594A3 Cd93 or use of soluble fragment thereof
10/21/2010US20100268329 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
10/21/2010US20100267835 Methods of treating disorders of trigeminalvascular activation
10/21/2010US20100267833 Compositions and methods for preventing or treating an inflammatory response
10/21/2010US20100267829 Pharmaceutical composition comprising low concentrations of environment pollutants
10/21/2010US20100267828 dha derivatives and their use as medicaments
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267776 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
10/21/2010US20100267774 P38 map kinase inhibitors
10/21/2010US20100267769 Substituted Bicyclocarboxyamide Compounds
10/21/2010US20100267767 Nuclear receptor binding agents
10/21/2010US20100267755 Pyrimidine derivatives
10/21/2010US20100267753 Methods of treating disorders associated with protein kinase ck2 activity
10/21/2010US20100267750 Methods and compositions for treating pain
10/21/2010US20100267741 Compounds, Compositions and Methods Comprising Pyrazole Derivatives
10/21/2010US20100267733 Synergistic Modulation of Microglial Activation by Nicotine and THC
10/21/2010US20100267725 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
10/21/2010US20100267719 Enhanced Indolinone Based Protein Kinase Inhibitors
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267705 Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267684 Use of biological surfactant as anti-inflammatory agent and tissue preservative solution
10/21/2010US20100267678 Flux-enabling compositions and methods for dermal delivery of drugs
10/21/2010US20100267675 Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100267665 Remedy for corneal diseases
10/21/2010US20100267662 Avenanthramide-containing compositions
10/21/2010US20100267651 T cell antigen receptor peptides
10/21/2010US20100267640 Method of Attenuating Neurogenic Swelling or Neurogenic Inflammation
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267618 Methods for treating congestive heart failure
10/21/2010US20100267140 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/21/2010US20100266707 Method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1
10/21/2010US20100266698 Use of insulin for the treatment of cartilaginous disorders
10/21/2010US20100266697 Mixed ligand surface-modified nanoparticles
10/21/2010US20100266696 Organic Compounds
10/21/2010US20100266683 New self emulsifying drug delivery system
10/21/2010US20100266619 Neutralizing Antibodies and Methods of Use Thereof
10/21/2010US20100266616 Polypeptides, antibody variable domains and antagonists
10/21/2010US20100266607 Antibody therapy for use in the digestive tract
10/21/2010US20100266605 Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect
10/21/2010US20100266597 Cytokine receptor zcytor17 multimers
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266582 Inhibition of il-17 production
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266562 Selective cytopheresis devices and related methods thereof
10/21/2010US20100266550 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266533 Death Domain Containing Receptors
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266528 Systemic Administration of Colony Stimulating Factors to Treat Amyloid Associated Disorders
10/21/2010US20100266527 Anti-microbial polymers and their compositions
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010US20100266499 Cytokine receptor zcytor17 multimers
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010CA2761064A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010CA2758934A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010CA2758929A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010CA2758918A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010CA2758542A1 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010CA2758484A1 Anti-viral compounds
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241567A1 Bicycloamine derivative
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2241315A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
10/20/2010EP2241313A1 Use of flavonoids to increase the bioavailability of hesperetin
10/20/2010EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof
10/20/2010EP2240453A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
10/20/2010EP2240450A1 Trpa1 antagonists
1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 1272